Whooping cough vaccines availability update
03 October 2016
GSK prioritises whooping cough vaccine availability for those most at risk of the disease and confirms uninterrupted supply of Boostrix® and Boostrix® IPV to all Australian State, Territory and Federal Government vaccination programs where Boostrix/Boostrix-IPV is the vaccine of choice.
BOOSTRIX®-IPV is a combined diphtheria-tetanus-acellular pertussis and polio virus vaccine used as a booster in adults and children 4-years and older.
GSK is prioritising supply of Boostrix-IPV to the Federal Goverment No Jab No PayProgram and any remaining stock (limited amount) will be made available to the private market.
We regret the inconvenience this may cause patients, pharmacists and doctors. If you need advice on alternatives, please speak to your healthcare professional.
For more information, please contact GSK medical information on 1800 033 109.